A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR

NCT02735369 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Proliferative Diabetic Retinopathy (PDR)

Interventions

DRUG: 2% OC-10X
DRUG: Placebo Comparator

Sponsor

OcuCure Therapeutics, Inc.

Collaborators

[object Object]